
|Articles|July 1, 2004
Experts elucidate management tips from glaucoma trials
Practitioners need to evaluate risk factors, life expectancy, patient preference
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
3
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5















































.png)


